GCM
Gladius Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-96
| Closed | -$32.1K | – | 57 |
|
|
2024
Q3 | $32.1K | Buy |
+96
| New | +$32.1K | ﹤0.01% | 166 |
|
|
2024
Q1 | – | Sell |
-121
| Closed | -$39.1K | – | 266 |
|
|
2023
Q4 | $39.1K | Buy |
121
+48
| +66% | +$15.5K | 0.01% | 134 |
|
|
2023
Q3 | $26.2K | Buy |
73
+18
| +33% | +$6.45K | ﹤0.01% | 233 |
|
|
2023
Q2 | $20.8K | Buy |
+55
| New | +$20.8K | ﹤0.01% | 215 |
|
|
2022
Q4 | – | Sell |
-75
| Closed | -$32K | – | 311 |
|
|
2022
Q3 | $32K | Buy |
+75
| New | +$32K | ﹤0.01% | 232 |
|
|
2022
Q2 | – | Sell |
-190
| Closed | -$108K | – | 299 |
|
|
2022
Q1 | $108K | Buy |
+190
| New | +$108K | 0.01% | 157 |
|